|
Market Closed -
OTC Markets
18:27:07 27/09/2024 +03
|
5-day change | 1st Jan Change | ||
| 8.500 USD | -.--% |
|
-.--% | - |
| 01/10/24 | Eiger BioPharmaceuticals Files for Chapter 11 Bankruptcy as Liquidation Plan Takes Effect | CI |
| 30/09/24 | Eiger BioPharmaceuticals, Inc. Went Out of Business | CI |
Stock exchange
OTC Markets
EIGR 8.500 $
-.--%
13.53K
$
| Markets | Price | Change | Volumes |
|---|
Performance
| 3 years | -29.76% | ||
| 5 years | -96.07% | ||
| 10 years | -98.06% |
Volumes
marketsCapital turnover ratio
0
Float rotation
0
Basic data
Market Cap (USD)
12,586,774
Net sales ()
16
Number of employees
25
Sales / Employee ()
1
Sales / Employee (USD)
1
Free-Float
86.47%
Free-Float capitalization (USD)
10,883,196
Indicators
Moving average 5 days
8.5
Moving average 100 days
8.438
Price spread / (MMA5)
-.--%
Price spread / (MMA100)
-0.72%
STIM
RSI 9 days
0
RSI 14 days
0
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | -.--% | -29.76% | 12.59M | |
| +0.11% | +1.98% | -0.04% | +9.69% | 46.18B | |
| -1.12% | +3.54% | +42.71% | +25.84% | 44.35B | |
| -3.04% | -6.10% | +335.86% | +501.23% | 42.21B | |
| -0.74% | +2.64% | +5.61% | +75.14% | 40.19B | |
| -0.50% | -0.77% | +11.86% | +40.41% | 29.83B | |
| -0.46% | +5.00% | +23.00% | +118.70% | 17.17B | |
| -0.97% | -9.38% | - | - | 15.7B | |
| -0.57% | +7.78% | +21.76% | +38.08% | 15.32B | |
| -3.28% | -0.95% | -6.34% | -37.29% | 13.09B | |
| Average | -1.06% | +1.50% | +48.27% | +82.45% | 26.4B | |
| Weighted average by Cap. | -1.11% | +1.63% | +69.64% | +117.21% |
Historical Quotes: Eiger BioPharmaceuticals
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 3 years | 1.1 |  | 16 |
| 5 years | 1.1 | | 300.64 |
| 10 years | 1.1 | | 540 |
Monthly variations
Annual variations
| 2024 | +26.21% | ||
| 2023 | -80.97% | ||
| 2022 | -77.26% | ||
| 2021 | -57.77% | ||
| 2020 | -17.52% | ||
| 2019 | +46.65% | ||
| 2018 | -27.17% | ||
| 2017 | +19.74% | ||
| 2016 | -26.69% |
- Stock Market
- Stocks
- EIGR Stock
- Quotes Eiger BioPharmaceuticals
Select your edition
All financial news and data tailored to specific country editions
